APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Growth Hormone Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Human Growth Hormone Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025182 pages

Choose your research edition.

Industry ResearchHuman Growth Hormone Drugs Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Growth Hormone Drugs Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Human Growth Hormone Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Growth Hormone Drugs Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Growth Hormone Drugs Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Human Growth Hormone Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Human Growth Hormone Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Human Growth Hormone Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Human Growth Hormone Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Human Growth Hormone Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Human Growth Hormone Drugs include Novo Nordisk A/S (Denmark), Merck KgaA (Germany), Eli Lilly and Company (US), Pfizer, Inc. (US), Ferring Holding SA (Switzerland), Sandoz International GmbH (Germany), GeneScience Pharmaceuticals Co., Ltd. (China) and Genentech, Inc. (US), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Human Growth Hormone Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Human Growth Hormone Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Human Growth Hormone Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Human Growth Hormone Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Human Growth Hormone Drugs Segment by Company

Novo Nordisk A/S (Denmark)

Merck KgaA (Germany)

Eli Lilly and Company (US)

Pfizer, Inc. (US)

Ferring Holding SA (Switzerland)

Sandoz International GmbH (Germany)

GeneScience Pharmaceuticals Co., Ltd. (China)

Genentech, Inc. (US)

Human Growth Hormone Drugs Segment by Type

Saizen

Genotropin

Humatrope

Norditropin

Omnitrope - the Somatropin Biosimilar

Somatropin Biopartners

Human Growth Hormone Drugs Segment by Application

Small for Gestational Age

Turner Syndrome

Prader-Willi Syndrome

Chronic Renal Insufficiency

Short Bowel Syndrome

Short Stature Homeobox Gene

Human Growth Hormone Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Growth Hormone Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Growth Hormone Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Growth Hormone Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Human Growth Hormone Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Human Growth Hormone Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Human Growth Hormone Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Human Growth Hormone Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Human Growth Hormone Drugs Industry Trends Table 2. Human Growth Hormone Drugs Industry Drivers Table 3. Human Growth Hormone Drugs Industry Opportunities and Challenges Table 4. Human Growth Hormone Drugs Industry Restraints Table 5. Global Human Growth Hormone Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Human Growth Hormone Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Human Growth Hormone Drugs Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Human Growth Hormone Drugs Sales Market Share by Manufacturers Table 9. Global Human Growth Hormone Drugs Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Human Growth Hormone Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Human Growth Hormone Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Human Growth Hormone Drugs Manufacturers, Product Type & Application Table 13. Global Human Growth Hormone Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Human Growth Hormone Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Saizen Table 17. Major Manufacturers of Genotropin Table 18. Major Manufacturers of Humatrope Table 19. Major Manufacturers of Norditropin Table 20. Major Manufacturers of Omnitrope - the Somatropin Biosimilar Table 21. Major Manufacturers of Somatropin Biopartners Table 22. Global Human Growth Hormone Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 23. Global Human Growth Hormone Drugs Sales by Type (2021-2026) & (K Units) Table 24. Global Human Growth Hormone Drugs Sales by Type (2027-2032) & (K Units) Table 25. Global Human Growth Hormone Drugs Sales Market Share by Type (2021-2026) Table 26. Global Human Growth Hormone Drugs Sales Market Share by Type (2027-2032) Table 27. Global Human Growth Hormone Drugs Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 28. Global Human Growth Hormone Drugs Revenue by Type (2021-2026) & (K Units) Table 29. Global Human Growth Hormone Drugs Revenue by Type (2027-2032) & (K Units) Table 30. Global Human Growth Hormone Drugs Revenue Market Share by Type (2021-2026) Table 31. Global Human Growth Hormone Drugs Revenue Market Share by Type (2027-2032) Table 32. Major Manufacturers of Small for Gestational Age Table 33. Major Manufacturers of Turner Syndrome Table 34. Major Manufacturers of Prader-Willi Syndrome Table 35. Major Manufacturers of Chronic Renal Insufficiency Table 36. Major Manufacturers of Short Bowel Syndrome Table 37. Major Manufacturers of Short Stature Homeobox Gene Table 38. Global Human Growth Hormone Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Human Growth Hormone Drugs Sales by Application (2021-2026) & (K Units) Table 40. Global Human Growth Hormone Drugs Sales by Application (2027-2032) & (K Units) Table 41. Global Human Growth Hormone Drugs Sales Market Share by Application (2021-2026) Table 42. Global Human Growth Hormone Drugs Sales Market Share by Application (2027-2032) Table 43. Global Human Growth Hormone Drugs Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 44. Global Human Growth Hormone Drugs Revenue by Application (2021-2026) & (K Units) Table 45. Global Human Growth Hormone Drugs Revenue by Application (2027-2032) & (K Units) Table 46. Global Human Growth Hormone Drugs Revenue Market Share by Application (2021-2026) Table 47. Global Human Growth Hormone Drugs Revenue Market Share by Application (2027-2032) Table 48. Global Human Growth Hormone Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 49. Global Human Growth Hormone Drugs Sales by Region (2021-2026) & (K Units) Table 50. Global Human Growth Hormone Drugs Sales Market Share by Region (2021-2026) Table 51. Global Human Growth Hormone Drugs Sales Forecasted by Region (2027-2032) & (K Units) Table 52. Global Human Growth Hormone Drugs Sales Forecasted Market Share by Region (2027-2032) Table 53. North America Human Growth Hormone Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. North America Human Growth Hormone Drugs Sales by Country (2021-2026) & (K Units) Table 55. North America Human Growth Hormone Drugs Sales by Country (2027-2032) & (K Units) Table 56. Europe Human Growth Hormone Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Europe Human Growth Hormone Drugs Sales by Country (2021-2026) & (K Units) Table 58. Europe Human Growth Hormone Drugs Sales by Country (2027-2032) & (K Units) Table 59. Asia Pacific Human Growth Hormone Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 60. Asia Pacific Human Growth Hormone Drugs Sales by Country (2021-2026) & (K Units) Table 61. Asia Pacific Human Growth Hormone Drugs Sales by Country (2027-2032) & (K Units) Table 62. South America, Middle East and Africa Human Growth Hormone Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 63. South America, Middle East and Africa Human Growth Hormone Drugs Sales by Country (2021-2026) & (K Units) Table 64. South America, Middle East and Africa Human Growth Hormone Drugs Sales by Country (2027-2032) & (K Units) Table 65. Global Human Growth Hormone Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 66. Global Human Growth Hormone Drugs Revenue by Region (2021-2026) & (US$ Million) Table 67. Global Human Growth Hormone Drugs Revenue by Region (2027-2032) & (US$ Million) Table 68. Global Human Growth Hormone Drugs Revenue Market Share by Region (2021-2026) Table 69. Global Human Growth Hormone Drugs Revenue Market Share by Region (2027-2032) Table 70. Novo Nordisk A/S (Denmark) Company Information Table 71. Novo Nordisk A/S (Denmark) Business Overview Table 72. Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Product Portfolio Table 74. Novo Nordisk A/S (Denmark) Recent Development Table 75. Merck KgaA (Germany) Company Information Table 76. Merck KgaA (Germany) Business Overview Table 77. Merck KgaA (Germany) Human Growth Hormone Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Merck KgaA (Germany) Human Growth Hormone Drugs Product Portfolio Table 79. Merck KgaA (Germany) Recent Development Table 80. Eli Lilly and Company (US) Company Information Table 81. Eli Lilly and Company (US) Business Overview Table 82. Eli Lilly and Company (US) Human Growth Hormone Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Eli Lilly and Company (US) Human Growth Hormone Drugs Product Portfolio Table 84. Eli Lilly and Company (US) Recent Development Table 85. Pfizer, Inc. (US) Company Information Table 86. Pfizer, Inc. (US) Business Overview Table 87. Pfizer, Inc. (US) Human Growth Hormone Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Pfizer, Inc. (US) Human Growth Hormone Drugs Product Portfolio Table 89. Pfizer, Inc. (US) Recent Development Table 90. Ferring Holding SA (Switzerland) Company Information Table 91. Ferring Holding SA (Switzerland) Business Overview Table 92. Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Product Portfolio Table 94. Ferring Holding SA (Switzerland) Recent Development Table 95. Sandoz International GmbH (Germany) Company Information Table 96. Sandoz International GmbH (Germany) Business Overview Table 97. Sandoz International GmbH (Germany) Human Growth Hormone Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Sandoz International GmbH (Germany) Human Growth Hormone Drugs Product Portfolio Table 99. Sandoz International GmbH (Germany) Recent Development Table 100. GeneScience Pharmaceuticals Co., Ltd. (China) Company Information Table 101. GeneScience Pharmaceuticals Co., Ltd. (China) Business Overview Table 102. GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Product Portfolio Table 104. GeneScience Pharmaceuticals Co., Ltd. (China) Recent Development Table 105. Genentech, Inc. (US) Company Information Table 106. Genentech, Inc. (US) Business Overview Table 107. Genentech, Inc. (US) Human Growth Hormone Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Genentech, Inc. (US) Human Growth Hormone Drugs Product Portfolio Table 109. Genentech, Inc. (US) Recent Development Table 110. Key Raw Materials Table 111. Raw Materials Key Suppliers Table 112. Human Growth Hormone Drugs Distributors List Table 113. Human Growth Hormone Drugs Customers List Table 114. Research Programs/Design for This Report Table 115. Authors List of This Report Table 116. Secondary Sources Table 117. Primary Sources List of Figures Figure 1. Human Growth Hormone Drugs Product Image Figure 2. Global Human Growth Hormone Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Growth Hormone Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Human Growth Hormone Drugs Sales (2021-2032) & (K Units) Figure 5. Global Human Growth Hormone Drugs Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Human Growth Hormone Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Saizen Image Figure 9. Genotropin Image Figure 10. Humatrope Image Figure 11. Norditropin Image Figure 12. Omnitrope - the Somatropin Biosimilar Image Figure 13. Somatropin Biopartners Image Figure 14. Global Human Growth Hormone Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Human Growth Hormone Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 16. Global Human Growth Hormone Drugs Sales Market Share by Type (2021-2032) Figure 17. Global Human Growth Hormone Drugs Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 18. Global Human Growth Hormone Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Human Growth Hormone Drugs Revenue Market Share by Type (2021-2032) Figure 20. Small for Gestational Age Image Figure 21. Turner Syndrome Image Figure 22. Prader-Willi Syndrome Image Figure 23. Chronic Renal Insufficiency Image Figure 24. Short Bowel Syndrome Image Figure 25. Short Stature Homeobox Gene Image Figure 26. Global Human Growth Hormone Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 27. Global Human Growth Hormone Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 28. Global Human Growth Hormone Drugs Sales Market Share by Application (2021-2032) Figure 29. Global Human Growth Hormone Drugs Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 30. Global Human Growth Hormone Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 31. Global Human Growth Hormone Drugs Revenue Market Share by Application (2021-2032) Figure 32. North America Human Growth Hormone Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 33. North America Human Growth Hormone Drugs Sales Market Share by Country (2021-2032) Figure 34. U.S. Human Growth Hormone Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Canada Human Growth Hormone Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Mexico Human Growth Hormone Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Europe Human Growth Hormone Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Europe Human Growth Hormone Drugs Sales Market Share by Country (2021-2032) Figure 39. Germany Human Growth Hormone Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 40. France Human Growth Hormone Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 41. U.K. Human Growth Hormone Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Italy Human Growth Hormone Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Netherlands Human Growth Hormone Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Asia Pacific Human Growth Hormone Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Asia Pacific Human Growth Hormone Drugs Sales Market Share by Country (2021-2032) Figure 46. China Human Growth Hormone Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Japan Human Growth Hormone Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Korea Human Growth Hormone Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Southeast Asia Human Growth Hormone Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 50. India Human Growth Hormone Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Australia Human Growth Hormone Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 52. South America, Middle East and Africa Human Growth Hormone Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 53. South America, Middle East and Africa Human Growth Hormone Drugs Sales Market Share by Country (2021-2032) Figure 54. Brazil Human Growth Hormone Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 55. South Africa Human Growth Hormone Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Saudi Arabia Human Growth Hormone Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Turkey Human Growth Hormone Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Argentina Human Growth Hormone Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 59. UAE Human Growth Hormone Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 60. Egypt Human Growth Hormone Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 61. Chile Human Growth Hormone Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 62. Global Human Growth Hormone Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 63. Global Human Growth Hormone Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 64. North America Human Growth Hormone Drugs Revenue (2021-2032) & (US$ Million) Figure 65. North America Human Growth Hormone Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Europe Human Growth Hormone Drugs Revenue (2021-2032) & (US$ Million) Figure 67. Europe Human Growth Hormone Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Asia-Pacific Human Growth Hormone Drugs Revenue (2021-2032) & (US$ Million) Figure 69. Asia-Pacific Human Growth Hormone Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. South America, Middle East and Africa Human Growth Hormone Drugs Revenue (2021-2032) & (US$ Million) Figure 71. South America, Middle East and Africa Human Growth Hormone Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 72. Human Growth Hormone Drugs Value Chain Figure 73. Manufacturing Cost Structure Figure 74. Human Growth Hormone Drugs Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Saizen
  • Genotropin
  • Humatrope
  • Norditropin
  • Omnitrope - the Somatropin Biosimilar
  • Somatropin Biopartners
Applications
  • Small for Gestational Age
  • Turner Syndrome
  • Prader-Willi Syndrome
  • Chronic Renal Insufficiency
  • Short Bowel Syndrome
  • Short Stature Homeobox Gene
Companies covered
  • Novo Nordisk A/S (Denmark)
  • Merck KgaA (Germany)
  • Eli Lilly and Company (US)
  • Pfizer, Inc. (US)
  • Ferring Holding SA (Switzerland)
  • Sandoz International GmbH (Germany)
  • GeneScience Pharmaceuticals Co., Ltd. (China)
  • Genentech, Inc. (US)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Human Growth Hormone Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Human Growth Hormone Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Human Growth Hormone Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Human Growth Hormone Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Human Growth Hormone Drugs Market Dynamics
  1. 2.1 Human Growth Hormone Drugs Industry Trends
  2. 2.2 Human Growth Hormone Drugs Industry Drivers
  3. 2.3 Human Growth Hormone Drugs Industry Opportunities and Challenges
  4. 2.4 Human Growth Hormone Drugs Industry Restraints
3 Human Growth Hormone Drugs Market by Manufacturers
  1. 3.1 Global Human Growth Hormone Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Human Growth Hormone Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Human Growth Hormone Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Human Growth Hormone Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Human Growth Hormone Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Human Growth Hormone Drugs Manufacturers, Product Type & Application
  7. 3.7 Global Human Growth Hormone Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Human Growth Hormone Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Human Growth Hormone Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Human Growth Hormone Drugs Tier 1, Tier 2, and Tier 3
4 Human Growth Hormone Drugs Market by Type
  1. 4.1 Human Growth Hormone Drugs Type Introduction
  2. 4.1.1 Saizen
  3. 4.1.2 Genotropin
  4. 4.1.3 Humatrope
  5. 4.1.4 Norditropin
  6. 4.1.5 Omnitrope - the Somatropin Biosimilar
  7. 4.1.6 Somatropin Biopartners
  8. 4.2 Global Human Growth Hormone Drugs Sales by Type
  9. 4.2.1 Global Human Growth Hormone Drugs Sales by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Human Growth Hormone Drugs Sales by Type (2021-2032)
  11. 4.2.3 Global Human Growth Hormone Drugs Sales Market Share by Type (2021-2032)
  12. 4.3 Global Human Growth Hormone Drugs Revenue by Type
  13. 4.3.1 Global Human Growth Hormone Drugs Revenue by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Human Growth Hormone Drugs Revenue by Type (2021-2032)
  15. 4.3.3 Global Human Growth Hormone Drugs Revenue Market Share by Type (2021-2032)
5 Human Growth Hormone Drugs Market by Application
  1. 5.1 Human Growth Hormone Drugs Application Introduction
  2. 5.1.1 Small for Gestational Age
  3. 5.1.2 Turner Syndrome
  4. 5.1.3 Prader-Willi Syndrome
  5. 5.1.4 Chronic Renal Insufficiency
  6. 5.1.5 Short Bowel Syndrome
  7. 5.1.6 Short Stature Homeobox Gene
  8. 5.2 Global Human Growth Hormone Drugs Sales by Application
  9. 5.2.1 Global Human Growth Hormone Drugs Sales by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global Human Growth Hormone Drugs Sales by Application (2021-2032)
  11. 5.2.3 Global Human Growth Hormone Drugs Sales Market Share by Application (2021-2032)
  12. 5.3 Global Human Growth Hormone Drugs Revenue by Application
  13. 5.3.1 Global Human Growth Hormone Drugs Revenue by Application (2021 VS 2025 VS 2032)
  14. 5.3.2 Global Human Growth Hormone Drugs Revenue by Application (2021-2032)
  15. 5.3.3 Global Human Growth Hormone Drugs Revenue Market Share by Application (2021-2032)
6 Global Human Growth Hormone Drugs Sales by Region
  1. 6.1 Global Human Growth Hormone Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Human Growth Hormone Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Human Growth Hormone Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global Human Growth Hormone Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Human Growth Hormone Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Human Growth Hormone Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Human Growth Hormone Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Human Growth Hormone Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Human Growth Hormone Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Human Growth Hormone Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Human Growth Hormone Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Human Growth Hormone Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Human Growth Hormone Drugs Revenue by Region
  1. 7.1 Global Human Growth Hormone Drugs Revenue by Region
  2. 7.1.1 Global Human Growth Hormone Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Human Growth Hormone Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global Human Growth Hormone Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global Human Growth Hormone Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Human Growth Hormone Drugs Revenue (2021-2032)
  8. 7.2.2 North America Human Growth Hormone Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Human Growth Hormone Drugs Revenue (2021-2032)
  11. 7.3.2 Europe Human Growth Hormone Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Human Growth Hormone Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Human Growth Hormone Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Human Growth Hormone Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Human Growth Hormone Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Novo Nordisk A/S (Denmark)
  2. 8.1.1 Novo Nordisk A/S (Denmark) Company Information
  3. 8.1.2 Novo Nordisk A/S (Denmark) Business Overview
  4. 8.1.3 Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Product Portfolio
  6. 8.1.5 Novo Nordisk A/S (Denmark) Recent Developments
  7. 8.2 Merck KgaA (Germany)
  8. 8.2.1 Merck KgaA (Germany) Company Information
  9. 8.2.2 Merck KgaA (Germany) Business Overview
  10. 8.2.3 Merck KgaA (Germany) Human Growth Hormone Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Merck KgaA (Germany) Human Growth Hormone Drugs Product Portfolio
  12. 8.2.5 Merck KgaA (Germany) Recent Developments
  13. 8.3 Eli Lilly and Company (US)
  14. 8.3.1 Eli Lilly and Company (US) Company Information
  15. 8.3.2 Eli Lilly and Company (US) Business Overview
  16. 8.3.3 Eli Lilly and Company (US) Human Growth Hormone Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Eli Lilly and Company (US) Human Growth Hormone Drugs Product Portfolio
  18. 8.3.5 Eli Lilly and Company (US) Recent Developments
  19. 8.4 Pfizer, Inc. (US)
  20. 8.4.1 Pfizer, Inc. (US) Company Information
  21. 8.4.2 Pfizer, Inc. (US) Business Overview
  22. 8.4.3 Pfizer, Inc. (US) Human Growth Hormone Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Pfizer, Inc. (US) Human Growth Hormone Drugs Product Portfolio
  24. 8.4.5 Pfizer, Inc. (US) Recent Developments
  25. 8.5 Ferring Holding SA (Switzerland)
  26. 8.5.1 Ferring Holding SA (Switzerland) Company Information
  27. 8.5.2 Ferring Holding SA (Switzerland) Business Overview
  28. 8.5.3 Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Product Portfolio
  30. 8.5.5 Ferring Holding SA (Switzerland) Recent Developments
  31. 8.6 Sandoz International GmbH (Germany)
  32. 8.6.1 Sandoz International GmbH (Germany) Company Information
  33. 8.6.2 Sandoz International GmbH (Germany) Business Overview
  34. 8.6.3 Sandoz International GmbH (Germany) Human Growth Hormone Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Sandoz International GmbH (Germany) Human Growth Hormone Drugs Product Portfolio
  36. 8.6.5 Sandoz International GmbH (Germany) Recent Developments
  37. 8.7 GeneScience Pharmaceuticals Co., Ltd. (China)
  38. 8.7.1 GeneScience Pharmaceuticals Co., Ltd. (China) Company Information
  39. 8.7.2 GeneScience Pharmaceuticals Co., Ltd. (China) Business Overview
  40. 8.7.3 GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Product Portfolio
  42. 8.7.5 GeneScience Pharmaceuticals Co., Ltd. (China) Recent Developments
  43. 8.8 Genentech, Inc. (US)
  44. 8.8.1 Genentech, Inc. (US) Company Information
  45. 8.8.2 Genentech, Inc. (US) Business Overview
  46. 8.8.3 Genentech, Inc. (US) Human Growth Hormone Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Genentech, Inc. (US) Human Growth Hormone Drugs Product Portfolio
  48. 8.8.5 Genentech, Inc. (US) Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Human Growth Hormone Drugs Value Chain Analysis
  2. 9.1.1 Human Growth Hormone Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Human Growth Hormone Drugs Production Mode & Process
  6. 9.2 Human Growth Hormone Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Human Growth Hormone Drugs Distributors
  9. 9.2.3 Human Growth Hormone Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst